-
Merck and Sanofi both buying smaller cancer oncology companies at big premiums — The latest from ASH2019 conference — Biopharma Dive’s drug launch of the year: Zolgensma — See more on our front page newsDismiss Notice
TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE -
Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.Dismiss Notice
Upper Management Update - UBU Update
Discussion in 'Alza' started by Anonymous, Oct 6, 2006 at 11:11 AM.
Tags:
Add Tags
Page 2 of 2
Page 2 of 2